Skip to main content

Socioeconomic and Environmental Drivers of Pediatric Malaria

March 30, 2026
Ashley Wade is a medical student at Icahn School of Medicine at Mount Sinai and is mentored by Ross Boyce, MD, MSc. In many parts of Sub‑Saharan Africa, malaria is still one of the main reasons children are hospitalized. In a recent study, Wade and Annika Gunderson, a UNC Epidemiology...

Tracking Respiratory Infections in People Living With HIV in Rural Uganda

March 19, 2026
Lauryn Ursery is a PhD student in epidemiology studying at the Gillings School of Global Public Health, mentored by Dr. Ross Boyce. In rural Western Uganda, people living with HIV face unique health risks, including viral acute respiratory infections (ARIs) such as the flu. Ursery presented a study led by...

Tracking Zika and Dengue: Insights into Maternal and Infant Immunity in Nicaragua

March 12, 2026
Omar Zepeda is a PhD student studying at the University of Costa Rica and a fellow of the Nicaraguan Emerging and Endemic Diseases (NEED) program. He is mentored by Filemon Bucardo, PhD. At the recent 4th Annual Global Health Symposium Zepeda presented his findings on the Zika and Dengue viruses...

Exploring the Link Between Gold Mining and Malaria in Tanzania

March 11, 2026
Claudia Gaither is a PhD student in Epidemiology studying at the Gillings School of Global Public Health, mentored by Michael Emch, PhD. At the 4th Annual Global Health Scholars Symposium, Gaither talked about the relationship between malaria prevalence and proximity to mineral processing pits in northwestern Tanzania, where gold mining...

At 75, Myron Cohen Isn’t Interested in Retiring

February 17, 2026
Dr. Myron Cohen, who has been an infectious disease researcher and administrator at UNC Chapel Hill for more than four decades, was lauded worldwide in 2011 for leading a seminal study showing a stunning result:  Treating people with HIV with antiretroviral drugs could keep them from passing along human immunodeficiency...

Inside the HIV‑Infected Brain: A Postdoctoral Fellow’s Quest to Understand Viral Persistence

December 11, 2025
Ciniso Shabangu shares how his scientific journey—from early hepatitis and cancer research in Taiwan to advanced NeuroHIV studies at the UNC HIV Cure Center—has shaped his commitment to understanding how viruses persist in the body. His work now focuses on uncovering how HIV hides in the brain and the technologies driving those discoveries. ...

A Neurology Students Impact in Zambia

December 11, 2025
Nzia Hall has felt drawn to adult neurology for quite some time. As president of the Student Interest Group in Neurology, she helped revive the organization’s UNC chapter and now finds herself in the midst of applying to multiple neurology residency programs.  During her neurology acting internship, Hall met Dr. Deanna...

Fighting Drug‑Resistant Malaria: An MD‑PhD Student’s Mission in Zanzibar and Beyond

December 11, 2025
Sean Connelly shares how a small‑town upbringing, a passion for community, and early research experiences led him to pursue a career dedicated to improving global health. Now an MD‑PhD student at the UNC School of Medicine, Connelly studies malaria drug resistance in East Africa, working with international partners to support...

Mutations and Molecular Insights: Undergraduate Studies Malaria Resistance in Kenya

December 3, 2025
Amogh Rao is an undergraduate student at the Gillings School of Global Public Health and a lab assistant in Infectious Diseases Epidemiology and Ecology Lab (IDEEL) at the Institute for Global Health and Infectious Diseases. This past summer, he visited Kenya to research malaria resistance and the threat of treatment...

Dr. Scott Commins Comments on First Death Caused by Tick Induced Meat Allergy

December 1, 2025
Dr. Scott Commins, a member of the Institute for Global Health and Infectious Diseases, commented on the death of a 47-year-old man from Alpha-Gal Syndrome in an NBC News story. Dr. Commins studies the tick-bite induced red meat allergy that affects a growing population and describes the biggest risk factors for severe reactions, such as...

From Protocols to Purple Bowl: Chapel Hill CRS Celebrates Success

November 11, 2025
The Institute’s Global HIV Clinical Trials Unit (CTU) has long been recognized for its scientific rigor, research excellence, and a consistent ability to meet complex regulatory compliance. Its systematic approach, vital to producing reliable and trustworthy evidence for new drug trials, ensures the safety and well-being of human participants are...

Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins

October 28, 2025
Artemisinin partial resistance, driven by Plasmodium falciparum K13 mutations, threatens malaria control. Zanzibar is vulnerable to the spread of artemisinin partial resistance but lacks molecular surveillance. Sean Connelly, an MD-PhD candidate, led a study with the IDEEL Lab team that sequenced samples in Zanzibar and mainland Tanzania, collected from 2022 to...